<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38185937</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>14</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1096-9071</ISSN><JournalIssue CitedMedium="Internet"><Volume>96</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Journal of medical virology</Title><ISOAbbreviation>J Med Virol</ISOAbbreviation></Journal><ArticleTitle>Generation and characterization of a humanized ACE2 mouse model to study long-term impacts of SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>e29349</StartPage><MedlinePgn>e29349</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/jmv.29349</ELocationID><Abstract><AbstractText>Although the COVID-19 pandemic has officially ended, the persistent challenge of long-COVID or post-acute COVID sequelae (PASC) continues to impact societies globally, highlighting the urgent need for ongoing research into its mechanisms and therapeutic approaches. Our team has recently developed a novel humanized ACE2 mouse model (hACE2ki) designed explicitly for long-COVID/PASC research. This model exhibits human ACE2 expression in tissue and cell-specific patterns akin to mouse Ace2. When we exposed young adult hACE2ki mice (6 weeks old) to various SARS-CoV-2 lineages, including WA, Delta, and Omicron, at a dose of 5&#x2009;&#xd7;&#x2009;10<sup>5</sup> PFU/mouse via nasal instillation, the mice demonstrated distinctive phenotypes characterized by differences in viral load in the lung, trachea, and nasal turbinate, weight loss, and changes in pro-inflammatory cytokines and immune cell profiles in bronchoalveolar lavage fluid. Notably, no mortality was observed in this age group. Further, to assess the model's relevance for long-COVID studies, we investigated tau protein pathologies, which are linked to Alzheimer's disease, in the brains of these mice post SARS-CoV-2 infection. Our findings revealed the accumulation and longitudinal propagation of tau, confirming the potential of our hACE2ki mouse model for preclinical studies of long-COVID.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. Journal of Medical Virology published by Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>Chang-Yong</ForeName><Initials>CY</Initials><AffiliationInfo><Affiliation>Division of Pediatric Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gadhave</LastName><ForeName>Kundlik</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Villano</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Molecular and Comparative Pathobiology, The Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pekosz</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Molecular Microbiology and Immunology, The Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mao</LastName><ForeName>Xiaobo</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Material Science and Engineering, Johns Hopkins Whiting School of Engineering, Institute for NanoBioTechnology, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Hongpeng</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-6783-7532</Identifier><AffiliationInfo><Affiliation>Division of Pediatric Surgery, Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG073291</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG005146</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R01AI148446-01A1</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>1R2AI14932101</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 AG05146</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI149321</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI148446</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>3R21AI149321-01S1</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AG073291</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 NS050274</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS107318</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01NS107318</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Med Virol</MedlineTA><NlmUniqueID>7705876</NlmUniqueID><ISSNLinking>0146-6615</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="C000705328">Ace2 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer's disease</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">humanized ACE2 mouse model</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">tau pathology</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>12</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>1</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38185937</ArticleId><ArticleId IdType="mid">NIHMS1953618</ArticleId><ArticleId IdType="pmc">PMC10783855</ArticleId><ArticleId IdType="doi">10.1002/jmv.29349</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Antonelli M, Pujol JC, Spector TD, Ourselin S &amp; Steves CJ Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet 399, 2263&#x2013;2264 (2022). 10.1016/S0140-6736(22)00941-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00941-2</ArticleId><ArticleId IdType="pmc">PMC9212672</ArticleId><ArticleId IdType="pubmed">35717982</ArticleId></ArticleIdList></Reference><Reference><Citation>Perumal R et al. Long COVID: a review and proposed visualization of the complexity of long COVID. Front Immunol 14, 1117464 (2023). 10.3389/fimmu.2023.1117464</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1117464</ArticleId><ArticleId IdType="pmc">PMC10157068</ArticleId><ArticleId IdType="pubmed">37153597</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia H, Yue X &amp; Lazartigues E ACE2 mouse models: a toolbox for cardiovascular and pulmonary research. Nat Commun 11, 5165 (2020). 10.1038/s41467-020-18880-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-18880-0</ArticleId><ArticleId IdType="pmc">PMC7560817</ArticleId><ArticleId IdType="pubmed">33057007</ArticleId></ArticleIdList></Reference><Reference><Citation>Shou S et al. Animal Models for COVID-19: Hamsters, Mouse, Ferret, Mink, Tree Shrew, and Non-human Primates. Front Microbiol 12, 626553 (2021). 10.3389/fmicb.2021.626553</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.626553</ArticleId><ArticleId IdType="pmc">PMC8438334</ArticleId><ArticleId IdType="pubmed">34531831</ArticleId></ArticleIdList></Reference><Reference><Citation>Golden JW et al. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease. JCI Insight 5 (2020). 10.1172/jci.insight.142032</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.142032</ArticleId><ArticleId IdType="pmc">PMC7566707</ArticleId><ArticleId IdType="pubmed">32841215</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH et al. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits. Front Immunol 13, 1055811 (2022). 10.3389/fimmu.2022.1055811</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1055811</ArticleId><ArticleId IdType="pmc">PMC9706212</ArticleId><ArticleId IdType="pubmed">36457995</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun SH et al. A Mouse Model of SARS-CoV-2 Infection and Pathogenesis. Cell Host Microbe 28, 124&#x2013;133 e124 (2020). 10.1016/j.chom.2020.05.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.05.020</ArticleId><ArticleId IdType="pmc">PMC7250783</ArticleId><ArticleId IdType="pubmed">32485164</ArticleId></ArticleIdList></Reference><Reference><Citation>Amalakanti S, Arepalli KVR &amp; Jillella JP Cognitive assessment in asymptomatic COVID-19 subjects. Virusdisease 32, 146&#x2013;149 (2021). 10.1007/s13337-021-00663-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13337-021-00663-w</ArticleId><ArticleId IdType="pmc">PMC7883942</ArticleId><ArticleId IdType="pubmed">33614860</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RL et al. Pathophysiology, diagnosis, and management of neuroinflammation in COVID-19. BMJ 382, e073923 (2023). 10.1136/bmj-2022-073923</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-073923</ArticleId><ArticleId IdType="pubmed">37595965</ArticleId></ArticleIdList></Reference><Reference><Citation>de Erausquin GA et al. Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer&#x2019;s Association Global Consortium. Alzheimers Dement (N Y) 8, e12348 (2022). 10.1002/trc2.12348</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12348</ArticleId><ArticleId IdType="pmc">PMC9494609</ArticleId><ArticleId IdType="pubmed">36185993</ArticleId></ArticleIdList></Reference><Reference><Citation>Javed A Neurological Associations of SARS-CoV-2 Infection: A Systematic Review. CNS Neurol Disord Drug Targets 21, 246&#x2013;258 (2022). 10.2174/1871527320666210216121211</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1871527320666210216121211</ArticleId><ArticleId IdType="pubmed">33593267</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura ZM, Nash RP, Laughon SL &amp; Rosenstein DL Neuropsychiatric Complications of COVID-19. Curr Psychiatry Rep 23, 25 (2021). 10.1007/s11920-021-01237-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11920-021-01237-9</ArticleId><ArticleId IdType="pmc">PMC7962429</ArticleId><ArticleId IdType="pubmed">33725218</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan D et al. Neurological complications and infection mechanism of SARS-COV-2. Signal Transduct Target Ther 6, 406 (2021). 10.1038/s41392-021-00818-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00818-7</ArticleId><ArticleId IdType="pmc">PMC8609271</ArticleId><ArticleId IdType="pubmed">34815399</ArticleId></ArticleIdList></Reference><Reference><Citation>Frontera JA et al. Comparison of serum neurodegenerative biomarkers among hospitalized COVID-19 patients versus non-COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer&#x2019;s dementia. Alzheimer&#x2019;s &amp; Dementia 18, 899&#x2013;910 (2022). 10.1002/alz.12556</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12556</ArticleId><ArticleId IdType="pmc">PMC9011610</ArticleId><ArticleId IdType="pubmed">35023610</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun B et al. Characterization and Biomarker Analyses of Post-COVID-19 Complications and Neurological Manifestations. Cells 10 (2021). 10.3390/cells10020386</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020386</ArticleId><ArticleId IdType="pmc">PMC7918597</ArticleId><ArticleId IdType="pubmed">33668514</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S et al. Plasma P-tau181 in Alzheimer&#x2019;s disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer&#x2019;s dementia. Nat Med 26, 379&#x2013;386 (2020). 10.1038/s41591-020-0755-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0755-1</ArticleId><ArticleId IdType="pubmed">32123385</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiken S et al. Alzheimer&#x2019;s-like signaling in brains of COVID-19 patients. Alzheimers Dement 18, 955&#x2013;965 (2022). 10.1002/alz.12558</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12558</ArticleId><ArticleId IdType="pmc">PMC9011576</ArticleId><ArticleId IdType="pubmed">35112786</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q &amp; Zhao H Long-term effects of SARS-CoV-2 infection on human brain and memory. Cell Death Discov 9, 196 (2023). 10.1038/s41420-023-01512-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-023-01512-z</ArticleId><ArticleId IdType="pmc">PMC10307823</ArticleId><ArticleId IdType="pubmed">37380640</ArticleId></ArticleIdList></Reference><Reference><Citation>Granholm AC Long-Term Effects of SARS-CoV-2 in the Brain: Clinical Consequences and Molecular Mechanisms. J Clin Med 12 (2023). 10.3390/jcm12093190</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12093190</ArticleId><ArticleId IdType="pmc">PMC10179128</ArticleId><ArticleId IdType="pubmed">37176630</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Golenbock D, Latz E, Morgan D &amp; Brown R Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther 12, 69 (2020). 10.1186/s13195-020-00640-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00640-3</ArticleId><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Primio C et al. Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neurons. PNAS Nexus 2, pgad282 (2023). 10.1093/pnasnexus/pgad282</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pnasnexus/pgad282</ArticleId><ArticleId IdType="pmc">PMC10508204</ArticleId><ArticleId IdType="pubmed">37731949</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani A et al. SARS-CoV-2 targets neurons of 3D human brain organoids. EMBO J 39, e106230 (2020). 10.15252/embj.2020106230</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106230</ArticleId><ArticleId IdType="pmc">PMC7560208</ArticleId><ArticleId IdType="pubmed">32876341</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaufer C et al. Microgliosis and neuronal proteinopathy in brain persist beyond viral clearance in SARS-CoV-2 hamster model. EBioMedicine 79, 103999 (2022). 10.1016/j.ebiom.2022.103999</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103999</ArticleId><ArticleId IdType="pmc">PMC9013202</ArticleId><ArticleId IdType="pubmed">35439679</ArticleId></ArticleIdList></Reference><Reference><Citation>James OG, Doraiswamy PM &amp; Borges-Neto S PET Imaging of Tau Pathology in Alzheimer&#x2019;s Disease and Tauopathies. Front Neurol 6, 38 (2015). 10.3389/fneur.2015.00038</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2015.00038</ArticleId><ArticleId IdType="pmc">PMC4353301</ArticleId><ArticleId IdType="pubmed">25806018</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson PT et al. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles &#x201c;do count&#x201d; when staging disease severity. J Neuropathol Exp Neurol 66, 1136&#x2013;1146 (2007). 10.1097/nen.0b013e31815c5efb</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e31815c5efb</ArticleId><ArticleId IdType="pmc">PMC3034246</ArticleId><ArticleId IdType="pubmed">18090922</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan R et al. ACE2 activator diminazene aceturate ameliorates Alzheimer&#x2019;s disease-like neuropathology and rescues cognitive impairment in SAMP8 mice. Aging (Albany NY) 12, 14819&#x2013;14829 (2020). 10.18632/aging.103544</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103544</ArticleId><ArticleId IdType="pmc">PMC7425432</ArticleId><ArticleId IdType="pubmed">32701063</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans CE et al. ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer&#x2019;s disease. Acta Neuropathol 139, 485&#x2013;502 (2020). 10.1007/s00401-019-02098-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-02098-6</ArticleId><ArticleId IdType="pmc">PMC7035243</ArticleId><ArticleId IdType="pubmed">31982938</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181, 271&#x2013;280 e278 (2020). 10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C et al. Pathological Tau transmission initiated by binding lymphocyte-activation gene 3. bioRxiv (2023). 10.1101/2023.05.16.541015</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.05.16.541015</ArticleId><ArticleId IdType="pmc">PMC5510615</ArticleId><ArticleId IdType="pubmed">27708076</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo JL et al. Unique pathological tau conformers from Alzheimer&#x2019;s brains transmit tau pathology in nontransgenic mice. J Exp Med 213, 2635&#x2013;2654 (2016). 10.1084/jem.20160833</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20160833</ArticleId><ArticleId IdType="pmc">PMC5110027</ArticleId><ArticleId IdType="pubmed">27810929</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S et al. Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2. Nat Commun 12, 5654 (2021). 10.1038/s41467-021-25903-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-25903-x</ArticleId><ArticleId IdType="pmc">PMC8476561</ArticleId><ArticleId IdType="pubmed">34580297</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B et al. SARS-CoV-2 spike D614G change enhances replication and transmission. Nature 592, 122&#x2013;127 (2021). 10.1038/s41586-021-03361-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03361-1</ArticleId><ArticleId IdType="pubmed">33636719</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez-Chamorro L et al. SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients. Viruses 13 (2021). 10.3390/v13091715</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13091715</ArticleId><ArticleId IdType="pmc">PMC8471465</ArticleId><ArticleId IdType="pubmed">34578296</ArticleId></ArticleIdList></Reference><Reference><Citation>Inde Z et al. Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 severity. Sci Adv 7 (2021). 10.1126/sciadv.abf8609</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.abf8609</ArticleId><ArticleId IdType="pmc">PMC8373124</ArticleId><ArticleId IdType="pubmed">34407940</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrehart T et al. Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children? Paediatr Respir Rev 44, 61&#x2013;69 (2022). 10.1016/j.prrv.2022.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2022.01.008</ArticleId><ArticleId IdType="pmc">PMC8823960</ArticleId><ArticleId IdType="pubmed">35227628</ArticleId></ArticleIdList></Reference><Reference><Citation>Berni Canani R et al. Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract. Front Pediatr 9, 697390 (2021). 10.3389/fped.2021.697390</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.697390</ArticleId><ArticleId IdType="pmc">PMC8355889</ArticleId><ArticleId IdType="pubmed">34395341</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloise E et al. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia. Am J Obstet Gynecol 224, 298 e291&#x2013;298 e298 (2021). 10.1016/j.ajog.2020.08.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajog.2020.08.055</ArticleId><ArticleId IdType="pmc">PMC7445125</ArticleId><ArticleId IdType="pubmed">32853537</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J et al. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Aging Cell 19 (2020). 10.1111/acel.13168</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13168</ArticleId><ArticleId IdType="pmc">PMC7323071</ArticleId><ArticleId IdType="pubmed">32558150</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q, Shults NV, Gychka SG, Harris BT &amp; Suzuki YJ Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer&#x2019;s Disease. Int J Mol Sci 22 (2021). 10.3390/ijms22041687</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22041687</ArticleId><ArticleId IdType="pmc">PMC7914443</ArticleId><ArticleId IdType="pubmed">33567524</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q, Shults NV, Harris BT &amp; Suzuki YJ Angiotensin-converting enzyme 2 (ACE2) is upregulated in Alzheimer&#x2019;s disease brain. bioRxiv (2020). 10.1101/2020.10.08.331157</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.10.08.331157</ArticleId><ArticleId IdType="pmc">PMC7914443</ArticleId><ArticleId IdType="pubmed">33567524</ArticleId></ArticleIdList></Reference><Reference><Citation>Inde Z et al. Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 disease severity. bioRxiv (2020). 10.1101/2020.09.13.276923</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.09.13.276923</ArticleId><ArticleId IdType="pmc">PMC8373124</ArticleId><ArticleId IdType="pubmed">34407940</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu M, Qiu L, Jia G, Guo R &amp; Leng Q Single-cell expression profiles of ACE2 and TMPRSS2 reveals potential vertical transmission and fetus infection of SARS-CoV-2. Aging (Albany NY) 12, 19880&#x2013;19897 (2020). 10.18632/aging.104015</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.104015</ArticleId><ArticleId IdType="pmc">PMC7655214</ArticleId><ArticleId IdType="pubmed">33104520</ArticleId></ArticleIdList></Reference><Reference><Citation>Maremanda KP, Sundar IK, Li D &amp; Rahman I Age-Dependent Assessment of Genes Involved in Cellular Senescence, Telomere, and Mitochondrial Pathways in Human Lung Tissue of Smokers, COPD, and IPF: Associations With SARS-CoV-2 COVID-19 ACE2-TMPRSS2-Furin-DPP4 Axis. Front Pharmacol 11, 584637 (2020). 10.3389/fphar.2020.584637</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.584637</ArticleId><ArticleId IdType="pmc">PMC7510459</ArticleId><ArticleId IdType="pubmed">33013423</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos KI, Papadopoulou A &amp; Aw TC A protective erythropoietin evolutionary landscape, NLRP3 inflammasome regulation, and multisystem inflammatory syndrome in children. Hum Cell 36, 26&#x2013;40 (2023). 10.1007/s13577-022-00819-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13577-022-00819-w</ArticleId><ArticleId IdType="pmc">PMC9618415</ArticleId><ArticleId IdType="pubmed">36310304</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues R &amp; Costa de Oliveira S The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review. Microorganisms 9 (2021). 10.3390/microorganisms9081692</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9081692</ArticleId><ArticleId IdType="pmc">PMC8398209</ArticleId><ArticleId IdType="pubmed">34442770</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeland U et al. Evidence for treatment with estradiol for women with SARS-CoV-2 infection. BMC Med 18, 369 (2020). 10.1186/s12916-020-01851-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-020-01851-z</ArticleId><ArticleId IdType="pmc">PMC7685778</ArticleId><ArticleId IdType="pubmed">33234138</ArticleId></ArticleIdList></Reference><Reference><Citation>Yee M, Cohen ED, Haak J, Dylag AM &amp; O&#x2019;Reilly MA Neonatal hyperoxia enhances age-dependent expression of SARS-CoV-2 receptors in mice. bioRxiv (2020). 10.1101/2020.07.22.215962</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.07.22.215962</ArticleId><ArticleId IdType="pmc">PMC7769981</ArticleId><ArticleId IdType="pubmed">33372179</ArticleId></ArticleIdList></Reference><Reference><Citation>Suryawanshi RK et al. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature 607, 351&#x2013;355 (2022). 10.1038/s41586-022-04865-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04865-0</ArticleId><ArticleId IdType="pmc">PMC9279157</ArticleId><ArticleId IdType="pubmed">35584773</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim S-H et al. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits. Frontiers in Immunology 13 (2022). 10.3389/fimmu.2022.1055811</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.1055811</ArticleId><ArticleId IdType="pmc">PMC9706212</ArticleId><ArticleId IdType="pubmed">36457995</ArticleId></ArticleIdList></Reference><Reference><Citation>Winkler ES et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function. Nat Immunol 21, 1327&#x2013;1335 (2020). 10.1038/s41590-020-0778-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-020-0778-2</ArticleId><ArticleId IdType="pmc">PMC7578095</ArticleId><ArticleId IdType="pubmed">32839612</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mammeri N, Gampp O, Duan P &amp; Hong M Membrane-induced tau amyloid fibrils. Commun Biol 6, 467 (2023). 10.1038/s42003-023-04847-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-023-04847-6</ArticleId><ArticleId IdType="pmc">PMC10147698</ArticleId><ArticleId IdType="pubmed">37117483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ezzat K et al. The viral protein corona directs viral pathogenesis and amyloid aggregation. Nat Commun 10, 2331 (2019). 10.1038/s41467-019-10192-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10192-2</ArticleId><ArticleId IdType="pmc">PMC6536551</ArticleId><ArticleId IdType="pubmed">31133680</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang AC et al. Dysregulation of brain and choroid plexus cell types in severe COVID-19. Nature 595, 565&#x2013;571 (2021). 10.1038/s41586-021-03710-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03710-0</ArticleId><ArticleId IdType="pmc">PMC8400927</ArticleId><ArticleId IdType="pubmed">34153974</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullen CK et al. Infectability of human BrainSphere neurons suggests neurotropism of SARS-CoV-2. ALTEX 37, 665&#x2013;671 (2020). 10.14573/altex.2006111</Citation><ArticleIdList><ArticleId IdType="doi">10.14573/altex.2006111</ArticleId><ArticleId IdType="pubmed">32591839</ArticleId></ArticleIdList></Reference><Reference><Citation>Piekut T et al. Infectious agents and Alzheimer&#x2019;s disease. J Integr Neurosci 21, 73 (2022). 10.31083/j.jin2102073</Citation><ArticleIdList><ArticleId IdType="doi">10.31083/j.jin2102073</ArticleId><ArticleId IdType="pubmed">35364661</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmi A et al. Detection of SARS-CoV-2 viral proteins and genomic sequences in human brainstem nuclei. NPJ Parkinsons Dis 9, 25 (2023). 10.1038/s41531-023-00467-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-023-00467-3</ArticleId><ArticleId IdType="pmc">PMC9924897</ArticleId><ArticleId IdType="pubmed">36781876</ArticleId></ArticleIdList></Reference><Reference><Citation>Nori W &amp; Ghani Zghair MA Omicron targets upper airways in pediatrics, elderly and unvaccinated population. World J Clin Cases 10, 12062&#x2013;12065 (2022). 10.12998/wjcc.v10.i32.12062</Citation><ArticleIdList><ArticleId IdType="doi">10.12998/wjcc.v10.i32.12062</ArticleId><ArticleId IdType="pmc">PMC9669854</ArticleId><ArticleId IdType="pubmed">36405264</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>